Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study (Q38627519)

4 September 2017

0 references

Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study (English)

1 reference

4 September 2017

1 reference

1 reference

10

Matthias Egger

0 references

David Sebag-Montefiore

9

David Sebag-Montefiore

0 references

Sven Trelle

Sven Trelle

3

0 references

Matthew Sperrin

Matthew Sperrin

7

0 references

Marcel Zwahlen

Marcel Zwahlen

2

0 references

Marcel van Herk

Marcel van Herk

8

0 references

author name string

Hema Sekhar

1

1 reference

4 September 2017

Lee Malcomson

4

1 reference

4 September 2017

Rohit Kochhar

5

1 reference

4 September 2017

Mark P Saunders

6

1 reference

4 September 2017

Andrew G Renehan

11

1 reference

4 September 2017

language of work or name

1 reference

9 August 2017

1 reference

full work available at URL

4 September 2017

http://eprints.whiterose.ac.uk/120111/

content deliverer

White Rose Research Online

object has role

postprint

0 references

published in

Lancet Oncology Commission

1 reference

High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Current treatment of anal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

International trends in anal cancer incidence rates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The rising incidence of anal cancer in England 1990-2010: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the Anus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

NCCN clinical practice guidelines in oncology. Anal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Anal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Advanced methods in meta-analysis: multivariate approach and meta-regression.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Treatment of epidermoid anal canal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Radiation treatment of epidermoid cancer of the anus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Predictors and patterns of recurrence after definitive chemoradiation for anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma--clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Long-term outcomes of chemoradiation for anal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

External beam radiotherapy ± chemotherapy in the treatment of anal canal cancer: a single-institute long-term experience on 100 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Inguinal sentinel lymph node biopsy for staging anal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Detection of brain metastases from small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Prostate cancer and the Will Rogers phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

The role of HPV in head and neck cancer and review of the HPV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Spurious precision? Meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930456-4

7 January 2021

10.1016/S1470-2045(17)30456-4

Identifiers

DOI

1 reference

10.1016/S1470-2045(17)30456-4

4 September 2017

0 references

CORE ID

141648329

0 references

Dimensions Publication ID

0 references

1 reference